entertainment -WSS

entertainment

author：hotspot 2025-09-30 23:05:48 - browse：8

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Wegovy, Zepbound and weight loss drugs that preserve muscle

hotspot

WSS

Drug cartel violence flares in western Mexico after vigilante leader's killing

Fatty liver disease was alleviated by Lilly’s ‘triple

Drug cartel violence flares in western Mexico after vigilante leader's killing

Drug cartel violence flares in western Mexico after vigilante leader's killing

Lupron, used to halt puberty in children, may cause lasting health problems

Childhood cancer progress stalls for Black, Hispanic kids: Report

focus

entertainment

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

George Santos makes 1st court appearance after pleading not guilty to 13 counts

PBM reforms clear House panel

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

ChatGPT in medicine: STAT answers readers' burning questions

Hubble vs. James Webb telescope images: See the difference

In Memoriam: Notable people who died in 2023

Skip the lead apron during X

entertainment

Crowdfunding for unproven stem cell procedures spreads misinformation

Ransomware attacks on hospitals: Study outlines patient impact

Lupron, used to halt puberty in children, may cause lasting health problems

CRISPR pioneers react to Casgevy, first gene

A daunting task: navigating dual Medicare, Medicaid eligibility

PBM reforms clear House panel

hotspot

hotspot

hotspot

hotspot